Skip to main content
. 2012 Apr 27;7(4):e36239. doi: 10.1371/journal.pone.0036239

Table 1. Patient and tumor characteristics for TSCC.

Patient and tumor characteristics All patients (n = 108) Patients with R10G (n = 21) Patients without R10G (n = 87) Patients with L83V (n = 43) Patients without L83V (n = 65)
Gender n % n % n % n % n %
Male 84 78% 17 81% 67 77% 32 74% 52 80%
Female 24 22% 4 19% 20 23% 11 26% 13 20%
Mean age 59.7 59.4 59.8 60.1 59.8
TNM classification
T1 24 22% 6 29% 18 21% 10 23% 14 22%
T2 44 41% 10 48% 34 39% 17 40% 27 42%
T3 24 22% 3 14% 21 24% 9 21% 15 23%
T4a-b 16 15% 2 10% 14 16% 7 16% 9 14%
N0 17 16% 4 19% 13 15% 5 12% 12 18%
N1 26 24% 4 19% 22 25% 14 33% 12 18%
N2a-c 63 58% 14 67% 49 56% 24 56% 39 60%
N3 3 3% 0 0% 3 3% 1 2% 2 3%
M0 106 98% 21 100% 85 98% 42 98% 64 98%
M1 2 2% 0 0% 2 2% 1 2% 1 2%
Stage
I 2 2% 1 5% 1 1% 2 5% 0 0%
II 7 6% 2 10% 5 6% 2 5% 5 8%
III 28 26% 5 24% 23 26% 11 26% 17 26%
IV 72 67% 14 67% 58 67% 29 67% 43 66%